Pharmaceutical QMS for documents, training, CAPA, change and audits.

• Six systems, one quality function

  Documents in SharePoint, training in an LMS, CAPA in TrackWise, deviation in spreadsheets, complaints in a CRM. Auditors trace one finding and the chain breaks.

• Change Control Doesn't Reach the Floor

  An SOP changes, the training reassigns, the equipment qualification status updates — but the operator at the kiosk doesn't see it. The next batch runs old.

• Complaint, Deviation, and CAPA Live Apart

  Same root cause, three different records, no aggregation. Trend analysis is a quarterly project, not a live view.

• One quality chain, end to end

  Document, training, deviation, CAPA, change, audit, supplier, complaint — one platform, one numbering, one audit trail.

• Change control that reaches the kiosk

  A controlled document revision triggers training reassignment and locks the relevant kiosk steps until operators re-train. No silent drift.

• Trending Built In

  Deviations, CAPAs, complaints, OOS, OOT — trended by product, line, root cause, and supplier. Quality reviews are live dashboards, not slide decks.

• ICH Q10 + Part 11 + Annex 11

  Designed for global pharma — same architecture passes FDA, EMA, MHRA, PMDA, ANVISA.

Pharmaceutical QMS on V5 across a quarter.

1. Floor Execution Feeds QMS. MES execution writes directly to QMS records; deviations open at the kiosk; supplier non-conformances route from receiving.
2. Change Control Scoped. Change records auto-scope across process, equipment, supplier, regulatory, and validation; review meeting walks live impact.
3. Findings Auto-Route to CAPA. Internal and external audit findings emit CAPAs with severity-driven SLA; effectiveness gated at closure.
4. Management Review on Live Data. Q10 §3.2.4 management review opens with the live dashboard; decisions emit as documented actions in the same record set.

Pharmaceutical QMS is a category dense with sales noise. These criteria separate a real eQMS from a CRUD app with the right module names.

• All Ten Elements Integrated

  Do documents, training, CAPA, change, deviation, complaint, supplier, audit, management review, and risk live on one record set? All ten elements share one record set with consistent audit trail and genealogy.

• Records-Execution Integration

  Does the QMS see what is happening on the floor — or only what was reported afterwards? Same platform runs MES, WMS, QMS — QMS sees execution in real time.

• ICH Q10 Lifecycle Awareness

  Does the system recognize pharmaceutical lifecycle as state — not just stage labels? Lifecycle is data; controls and signature flows adjust per state.

• Document control with training linkage

  Does a document revision auto-assign training and lock the floor until current? Revision triggers training reassignment and kiosk lockout for non-current operators.

• Change Control with Risk-Driven Scope

  Is change control risk-driven with scope across process, equipment, supplier, regulatory, and validation impact? Change control assesses scope across all five impact dimensions automatically.

• Audit-to-CAPA closed loop

  Do audit findings auto-route to CAPA with severity-driven SLA? Findings auto-route to CAPA with severity, owner, SLA — and gate effectiveness.

• Management Review as Live Data

  Is management review a live dashboard — not a slide deck? Live dashboards aggregate QMS, MES, and supplier data; the review meeting walks live data.

• Annex 11 + Part 11 + ICH Q10 in one footprint

  Does the same architecture satisfy FDA, EMA, MHRA, PMDA, and ICH-aligned regulators? One architecture, multi-regulator outputs.

How V5 eQMS compares to typical alternatives.

The clauses pharmaceutical inspectors weigh most.

• ICH Q10 §1.6

  Lifecycle state drives controls; development, transfer, commercial, and discontinuation states are first-class in V5.

• ICH Q10 §3.2.1

  Live monitoring from MES feeds the QMS; trending is continuous, not retrospective.

• ICH Q10 §3.2.2

  Forced source-record linkage and effectiveness verification; covered in detail in V5 CAPA pillar.

• ICH Q10 §3.2.3

  Five-dimension impact scoping; change-driven re-validation, training reassignment, and supplier requalification fire automatically.

• ICH Q10 §3.2.4

  Live dashboards anchor management review as a continuous process.

• 21 CFR 211.180(e)

  Annual product quality review (PQR / APR) generates from the live record set.

• EU GMP Chapter 1 §1.4

  PQS, GMP, and QRM share one record set in V5; risk artifacts link directly to controls.

• 21 CFR Part 11 + EU GMP Annex 11

  Architecture-level compliance covered in the Part 11 pillar.

• 21 CFR 210 / 211 (cGMP for finished pharmaceuticals)
• 21 CFR Part 11 (electronic records & signatures)
• EU GMP Part I (medicinal products) + Annex 11
• ICH Q7 (APIs), Q8 (development), Q9 (risk), Q10 (PQS)
• PIC/S PI 011

• Pharma
• Veterinary Pharma
• Biotech
• Radiopharmaceuticals
• Document control
• Audits & CAPA
• Skills Matrix & Training
• 21 CFR Part 11
• QMS
• Pharmaceutical Quality System (ICH Q10)
• Change Control

What modules does the V5 pharma QMS include?

Document control, training & skills matrix, deviation, CAPA, change control, internal & external audits, supplier quality, complaints, and annual product review — all on one Part 11 / Annex 11 platform.

Is V5 aligned with ICH Q10?

Yes. V5 implements the four ICH Q10 elements — process performance & product quality monitoring, CAPA, change management, and management review — as live, interconnected workflows rather than separate logs.

Does V5 support multi-site, multi-country pharma operations?

Yes. One tenant can host multiple sites with site-specific SOPs, training matrices, and document hierarchies — while quality leadership sees aggregated trending across the network.

What about validation?

With Enterprise, the IQ/OQ package and validation support are included, scoped in your quote. Customers run a delta — not a full re-validation.